Twilight: A randomized trial of ticagrelor monotherapy versus ticagrelor plus aspirin beginning at 3 months in High-risk patients undergoing percutaneous coronary intervention

Johny Nicolas, Usman Baber, Roxana Mehran

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Twilight: A randomized trial of ticagrelor monotherapy versus ticagrelor plus aspirin beginning at 3 months in High-risk patients undergoing percutaneous coronary intervention'. Together they form a unique fingerprint.

Medicine & Life Sciences